- Anniversary/History
- Membership
- Publications
- Resources
- Education
- Events
- Advocacy
- Careers
- About
- For Pain Patients and Professionals
Papers: 18 Feb 2023 - 24 Feb 2023
RESEARCH TYPE:
Clinical
Human Studies, Molecular/Cellular, Pharmacology/Drug Development
PAIN TYPE:
Arthritis, Inflammation/Inflammatory
2023 Feb
Br J Pain
17
1
Autologous conditioned serum is a product of blood origin, with fragmented evidence of therapeutic properties in osteoarthritis chronic pain. This pilot observational prospective study aimed to evaluate the feasibility of a treatment with conditional autologous serum (ACS) in patients with severe chronic pain and grade I-III osteoarthritis and to describe its cytokine content.